Ellicott City, MD – At the Society for Clinical Research Sites (SCRS) Asia-Pac Site Solutions Summit in Melbourne, Australia on July 14-15, SCRS and ARCS Australia, announced the signing of an MOU to explore collaboration and promote educational offerings for their respective members. SCRS’ 2017 Asia-Pac Site Solutions Summit will coincide with ACRS’ 2017 National Congress in Sydney. “SCRS represents clinical research sites around the globe. The MOU and planned partnership with ARCS Australia extends the reach of SCRS’ advocacy and education offerings,” said Christine Pierre, President of SCRS. “The members of both organizations will greatly benefit from a partnership and we are thrilled to be forging this relationship with ACRS.” “It’s about what is best for our ARCS members’ said Dr Shanny Dyer, CEO of ARCS Australia. “By setting up a partnership with SCRS we are looking to ensure our members can access information with a focus on sites and have a one-stop knowledge shop.” About SCRS SCRS is a global trade organization founded in 2012 which represents over 2,800 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org. About ARCS Australia ARCS supports the education, training and networking of individuals and provide representation for member interests for those working in the scientific disciplines of regulation, clinical research, health economics, medical affairs, medical information, pharmacovigilance and associated disciplines in the pharmaceutical and medical devices sectors. Membership is on an individual basis and currently stands at approximately 2,000. Visit ARCS.com.au.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Vabysmo Shows Significant Vision Improvement for Diabetic Macular Edema in Underrepresented Patients
October 22nd 2024Phase IV ELEVATUM trial results show that one year of treatment with Vabysmo significantly improved vision in underrepresented racial and ethnic groups with diabetic macular edema, supporting the drug's efficacy and safety across diverse populations.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Clesrovimab Shows Significant Reduction in RSV Infections, Hospitalizations in Infants
October 18th 2024Merck's investigational monoclonal antibody, clesrovimab, shows significant efficacy in reducing respiratory syncytial virus-related infections and hospitalizations in infants, with a favorable safety profile.